Inactive Ingredient Search for Approved Drug Products

• Share
• Tweet
• Linkedin
• Pin it
• More sharing options
  • Linkedin
  • Pin it
• Email
• Print

Search Names Beginning with X

Inactive Ingredient	Route	Dosage Form	CAS Number	UNII	Maximum Potency per unit dose	Maximum Daily Exposure (MDE)	Record Updated
XANTHAN GUM	OPHTHALMIC	SOLUTION	11138662	TTV12P4NEE	0.6%w/v
XANTHAN GUM	OPHTHALMIC	SOLUTION, GEL FORMING, EXTENDED RELEASE	11138662	TTV12P4NEE	0.6%w/w
XANTHAN GUM	OPHTHALMIC	SUSPENSION	11138662	TTV12P4NEE	0.6%w/w
XANTHAN GUM	ORAL	CAPSULE	11138662	TTV12P4NEE	0.01mg
XANTHAN GUM	ORAL	CAPSULE, EXTENDED RELEASE	11138662	TTV12P4NEE	0.16mg
XANTHAN GUM	ORAL	FILM, SOLUBLE	11138662	TTV12P4NEE		1mg
XANTHAN GUM	ORAL	GRANULE, FOR SUSPENSION	11138662	TTV12P4NEE		450mg	Y
XANTHAN GUM	ORAL	LIQUID, EXTENDED RELEASE	11138662	TTV12P4NEE		50mg
XANTHAN GUM	ORAL	LOZENGE	11138662	TTV12P4NEE		1264mg
XANTHAN GUM	ORAL	PASTE	11138662	TTV12P4NEE	35mg/1ml
XANTHAN GUM	ORAL	POWDER	11138662	TTV12P4NEE	275mg
XANTHAN GUM	ORAL	POWDER, FOR SOLUTION	11138662	TTV12P4NEE	10mg/5ml
XANTHAN GUM	ORAL	POWDER, FOR SUSPENSION	11138662	TTV12P4NEE		600mg
XANTHAN GUM	ORAL	SOLUTION	11138662	TTV12P4NEE		15mg
XANTHAN GUM	ORAL	SUSPENSION	11138662	TTV12P4NEE		150mg
XANTHAN GUM	ORAL	SUSPENSION, EXTENDED RELEASE	11138662	TTV12P4NEE	186.8mg
XANTHAN GUM	ORAL	SUSPENSION/ DROPS	11138662	TTV12P4NEE	2.9mg/1ml
XANTHAN GUM	ORAL	TABLET	11138662	TTV12P4NEE		56mg
XANTHAN GUM	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE	11138662	TTV12P4NEE		6mg	Y
XANTHAN GUM	ORAL	TABLET, EXTENDED RELEASE	11138662	TTV12P4NEE		528mg	Y
XANTHAN GUM	ORAL	TABLET, FILM COATED	11138662	TTV12P4NEE	0.08mg
XANTHAN GUM	ORAL	TABLET, FILM COATED, EXTENDED RELEASE	11138662	TTV12P4NEE	0.03mg
XANTHAN GUM	ORAL	TABLET, ORALLY DISINTEGRATING	11138662	TTV12P4NEE	0.15mg
XANTHAN GUM	ORAL	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	11138662	TTV12P4NEE		18mg
XANTHAN GUM	ORAL	TROCHE	11138662	TTV12P4NEE		184mg
XANTHAN GUM	RECTAL	ENEMA	11138662	TTV12P4NEE	0.25%w/v
XANTHAN GUM	RECTAL	SUSPENSION	11138662	TTV12P4NEE	0.06%w/v
XANTHAN GUM	TOPICAL	AEROSOL, FOAM	11138662	TTV12P4NEE	0.27%w/w
XANTHAN GUM	TOPICAL	CREAM	11138662	TTV12P4NEE		46mg	Y
XANTHAN GUM	TOPICAL	GEL	11138662	TTV12P4NEE	2.85%w/w
XANTHAN GUM	TOPICAL	LOTION	11138662	TTV12P4NEE	0.3%w/v
XANTHAN GUM	TOPICAL	SUSPENSION	11138662	TTV12P4NEE	0.11%w/w
XYLITOL	BUCCAL	GUM, CHEWING	87990	VCQ006KQ1E		9543mg	Y
XYLITOL	ORAL	FILM, SOLUBLE	87990	VCQ006KQ1E	4.76mg
XYLITOL	ORAL	PASTE	87990	VCQ006KQ1E	6mg/1ml
XYLITOL	ORAL	POWDER, FOR SUSPENSION	87990	VCQ006KQ1E	4223mg
XYLITOL	ORAL	SOLUTION	87990	VCQ006KQ1E		21600mg
XYLITOL	ORAL	SUSPENSION	87990	VCQ006KQ1E		1500mg
XYLITOL	ORAL	SUSPENSION, EXTENDED RELEASE	87990	VCQ006KQ1E		9000mg
XYLITOL	ORAL	TABLET	87990	VCQ006KQ1E	15.04mg
XYLITOL	ORAL	TABLET, EXTENDED RELEASE	87990	VCQ006KQ1E	86mg		Y
XYLITOL	ORAL	TABLET, FILM COATED, EXTENDED RELEASE	87990	VCQ006KQ1E		72mg
XYLITOL	ORAL	TABLET, ORALLY DISINTEGRATING	87990	VCQ006KQ1E	80mg
XYLITOL	SUBLINGUAL	SPRAY	87990	VCQ006KQ1E		22mg	Y

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021